Antibodies News and Research

RSS
Scientists develop a promising new approach to potentially treat Alzheimer's disease

Scientists develop a promising new approach to potentially treat Alzheimer's disease

15 Nov 2021
Promising results from Phase II REGEN-COV study

Promising results from Phase II REGEN-COV study

15 Nov 2021
Potential COVID-19 nasal spray vaccine shows promise in mice

Potential COVID-19 nasal spray vaccine shows promise in mice

15 Nov 2021
Smiths Detection: Innovative technology in biothreat detection

Smiths Detection: Innovative technology in biothreat detection

From Smiths Detection 15 Nov 2021
A study of livestock exposure to the SARS-CoV-2 virus

A study of livestock exposure to the SARS-CoV-2 virus

14 Nov 2021
The case for vaccinating children under 12 against COVID-19

The case for vaccinating children under 12 against COVID-19

14 Nov 2021
Increased risk of breakthrough SARS-CoV-2 infection with ChAdOx1 compared to BNT162b2 vaccine

Increased risk of breakthrough SARS-CoV-2 infection with ChAdOx1 compared to BNT162b2 vaccine

14 Nov 2021
Partial resistance to neutralizing antibodies and enhanced transmissibility of SARS-CoV-2 Delta variant

Partial resistance to neutralizing antibodies and enhanced transmissibility of SARS-CoV-2 Delta variant

14 Nov 2021
Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

12 Nov 2021
NanoTCE technology shows promise for treatment of acute myeloid leukemia

NanoTCE technology shows promise for treatment of acute myeloid leukemia

12 Nov 2021
New findings about naturally acquired immunity may help improve existing malaria vaccines

New findings about naturally acquired immunity may help improve existing malaria vaccines

12 Nov 2021
Higher order protein catenation leads to the development of artificial antibodies

Higher order protein catenation leads to the development of artificial antibodies

12 Nov 2021
COVID-19 vaccination humoral immune response in individuals with diabetes

COVID-19 vaccination humoral immune response in individuals with diabetes

12 Nov 2021
Immune responses with and without previous SARS-CoV-2 infection following single BNT162b2 vaccine dose

Immune responses with and without previous SARS-CoV-2 infection following single BNT162b2 vaccine dose

12 Nov 2021
Impact of mutations on binding affinity of SARS-CoV-2 variants with ACE2 and existing antibodies

Impact of mutations on binding affinity of SARS-CoV-2 variants with ACE2 and existing antibodies

12 Nov 2021
Study investigates the degree of Covid-19 vaccination protection in dialysis patients

Study investigates the degree of Covid-19 vaccination protection in dialysis patients

12 Nov 2021
Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program

Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program

11 Nov 2021
Long-lasting anti-spike and anti-membrane antibodies can differentiate between COVID-19 infection and vaccination

Long-lasting anti-spike and anti-membrane antibodies can differentiate between COVID-19 infection and vaccination

11 Nov 2021
New Delta sublineage shows no additional resistance to neutralization

New Delta sublineage shows no additional resistance to neutralization

11 Nov 2021
Immunity following COVID-19 vaccination and natural infection in India

Immunity following COVID-19 vaccination and natural infection in India

11 Nov 2021

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback